ArticleJournal of diabetes and metabolic disorders2025
Long-term trends in diabetes mellitus and sepsis-related mortality in the united states: a population-based retrospective analysis (1999-2024).
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Host-Clinical Integrated Prediction Model for Early Sepsis Risk in Diabetic Patients with Acute Infections: Development and Internal Validation.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetes mellitus (DM) is a chronic metabolic disorder that increases susceptibility to severe infections, including sepsis, a leading global cause of mortality. Individuals with DM face heightened sepsis risk due to immune dysfunction, metabolic disturbances, and hyperglycemia. Understanding long-term trends in sepsis-related mortality among patients with DM is essential to guide targeted prevention and management strategies. Methods: We conducted a population-based study using CDC WONDER mortality data from 1999 to 2024. Sepsis-related deaths in patients with DM were identified via ICD-10 codes (E10-E14; A02.1, A22.7, A26.7, A32.7, A40.0-A41.9, A42.7, B37.7). Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated and stratified by demographic, geographic, and urbanization characteristics. Temporal trends were analyzed using Joinpoint regression to estimate annual percent change (APC). Results: Between 1999 and 2024, 511,490 sepsis-related deaths occurred in patients with DM, most frequently in individuals aged 65 and older and in medical facilities. AAMRs declined significantly from 1999 to 2018, rose sharply from 2018 to 2021, and declined again from 2021 to 2024. Mortality was higher among men, non-Hispanic (NH) American Indian/Alaska Native and NH Black populations, residents of the South, and nonmetropolitan areas. Conclusion: Sepsis remains a major cause of death among patients with DM in the U.S., with persistent disparities by sex, race, region, and urbanization. The pandemic-era surge in mortality underscores the vulnerability of this population to infectious threats. Targeted prevention, timely sepsis recognition, and evidence-based management, coupled with addressing social determinants of health, are essential to reduce this burden. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01773-8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.